Evo Fund lowers stake in Delta-Fly Pharma to 22.71%
Stake history
Summary
Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2026-09-16 10:36 JST concerning Delta-Fly Pharma, Inc. Reported holding ratio: 22.71%, previous report: 32.11%.